MATK: Summary for Martek Biosciences Corporation - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 10:30am EST - Canadian Markets close in 5 hours and 30 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Martek Biosciences Corp. (MATK)

At 10:13 EST: 18.055 USD

0.005 (0.03%)

MORE ON MATK

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Martek Biosciences Corporation (NasdaqNM:MATK) Delayed quote data

Last Trade:	18.055 USD
Trade Time:	10:13AM EST
Change:	0.005 (0.03%)
Prev Close:	18.05
Open:	17.97
Bid:	18.05 x 800
Ask:	18.07 x 200
1y Target Est:	31.83

Day's Range:	17.91 - 18.17
52wk Range:	15.36 - 31.35
Volume:	33,542
Avg Vol (3m):	318,215
Market Cap:	600.13M
P/E (ttm):	18.39
EPS (ttm):	0.982
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add MATK to Portfolio

Download Data

HEADLINES

•	Lightning Round OT: Martek Biosciences, Valmont Industries and More
	at CNBC (Thu, Nov 19)

•	Algae Biofuels Have a Promising Future
	at Seeking Alpha (Fri, Nov 13)

•	Martek Biosciences: Can It Turn Algae into Gold, or at the Least Oil?
	at Seeking Alpha (Fri, Oct 30)

•	Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst
	Wall Street Transcript (Tue, Oct 20)

•	Martek's life'sDHA(TM) Featured in New Nutrioli DHA Cooking Oil from Ragasa
	PRNewswire (Mon, Sep 21)

•	MARTEK BIOSCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Fri, Sep 18)

•	MARTEK BIOSCIENCES CORP Financials
	EDGAR Online Financials (Thu, Sep 17)

•	Martek Announces Addition to Its Board of Directors
	PRNewswire (Wed, Sep 16)

•	Martek to Present at Two Upcoming Investor Conferences
	PRNewswire (Tue, Sep 15)

•	Martek Announces Settlement of Patent Dispute with Capsugel France Capsugel to Purchase DHA from Martek
	PRNewswire (Thu, Sep 10)

•	MARTEK BIOSCIENCES CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Wed, Sep 9)

•	Federal Circuit Rules in Martek's Favor in Appeal of Patent Infringement Case Martek Wins on All Counts Against Lonza
	PRNewswire (Tue, Sep 8)

More Headlines for MATK...

ANALYST

EPS Est (next year) (Oct-08) :	0.94
EPS Est (in 2 years) (Oct-09) :	1.12
Avg Rec (current)*:	2.8
PEG Ratio:	1.32

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Martek Biosciences Corporation engages in the development and commercialization of novel products from microalgae, fungi, and other microbes primarily in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•